Combined effect of coenzyme Q10 and fenofibrate on forearm microcirculatory function in type 2 diabetes (Q44430840)

2 December 2017

title

Combined effect of coenzyme Q10 and fenofibrate on forearm microcirculatory function in type 2 diabetes (English)

1 reference

2 December 2017

0 references

1 reference

2

Gerald F Watts

1 reference

2 December 2017

David A Playford

1

1 reference

2 December 2017

Kevin D Croft

series ordinal

3

1 reference

2 December 2017

Valerie Burke

series ordinal

4

1 reference

2 December 2017

language of work or name

1 reference

1 May 2003

1 reference

2 December 2017

1 reference

2 December 2017

volume

168

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

169-179

1 reference

Dyslipoproteinaemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes mellitus: an hypothesis

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Oxidative stress and diabetic vascular complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: role of dyslipidaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Low-density lipoprotein size, high-density lipoprotein concentration, and endothelial dysfunction in non-insulin-dependent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

The relationships between post-prandial lipaemia, endothelial function and oxidative stress in healthy individuals and patients with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Fibrates, dyslipoproteinaemia and cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial--FAT).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Dietary and pharmacological antioxidants in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Vitamin E supplementation improves endothelial function in type I diabetes mellitus: a randomized, placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Effect of oral vitamin E (alpha-tocopherol) supplementation on vascular endothelial function in Type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Oral treatment with an antioxidant (raxofelast) reduces oxidative stress and improves endothelial function in men with type II diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: protective effect of vitamin C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Beneficial effects of alpha-lipoic acid and ascorbic acid on endothelium-dependent, nitric oxide-mediated vasodilation in diabetic patients: relation to parameters of oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

The participation of coenzyme Q in free radical production and antioxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Coenzyme Q versus hypertension: does CoQ decrease endothelial superoxide generation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Cosupplementation with coenzyme Q prevents the prooxidant effect of alpha-tocopherol and increases the resistance of LDL to transition metal-dependent oxidation initiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

A role for reduced coenzyme Q in atherosclerosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Simultaneous determination of tocopherols, ubiquinols, and ubiquinones in blood, plasma, tissue homogenates, and subcellular fractions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Vitamin E ingestion does not improve arterial endothelial dysfunction in older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Gemfibrozil improves insulin sensitivity and flow-mediated vasodilatation in type 2 diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Endothelium-dependent hyperpolarization. Beyond nitric oxide and cyclic GMP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Oxidative stress and nitric oxide related parameters in type II diabetes mellitus: effects of glycemic control.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Endothelial dysfunction in diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

The reaction of nitric oxide with ubiquinol: kinetic properties and biological significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Indices of lipid peroxidation in vivo: strengths and limitations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Fenofibrate raises plasma homocysteine levels in the fasted and fed states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2802%2900417-3

10.1016/S0021-9150(02)00417-3

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference